Search results
Results from the WOW.Com Content Network
Dydrogesterone, sold under the brand name Duphaston among others, [1] is a progestin medication which is used for a variety of indications, including threatened or recurrent miscarriage during pregnancy, dysfunctional bleeding, infertility due to luteal insufficiency, dysmenorrhea, endometriosis, secondary amenorrhea, irregular cycles, premenstrual syndrome, and as a component of menopausal ...
Superficial moist heat is a great alternative can help calm abdominal muscle cramps associated with dysmenorrhea without the adverse effects of menstruation. Moist heat can also improve pelvic circulation that further helps reduce pain. [24] Heat therapy is shown to assist women with pain and reduce the duration of the first stage of labor.
Androgen replacement therapy formulations and dosages used in women Route Medication Major brand names Form Dosage Oral: Testosterone undecanoate: Andriol, Jatenzo: Capsule: 40–80 mg 1x/1–2 days Methyltestosterone: Metandren, Estratest: Tablet: 0.5–10 mg/day Fluoxymesterone: Halotestin: Tablet: 1–2.5 mg 1x/1–2 days Normethandrone a ...
Dysmenorrhea occurs less often in those who exercise regularly and those who have children early in life. [1] Treatment may include the use of a heating pad. [3] Medications that may help include NSAIDs such as ibuprofen, hormonal birth control and the IUD with progestogen. [1] [3] Taking vitamin B1 or magnesium may help. [2]
[4] [5] [2] [3] [6] It is also indicated for the treatment of moderate acne, premenstrual syndrome (PMS), premenstrual dysphoric disorder (PMDD), and dysmenorrhea (painful menstruation) in women. [5] The medication is taken by mouth and contains 30 μg EE and 3 mg DRSP per tablet (brand names Yasmin, others) or 20 μg EE and 3 mg DRSP per ...
Growth hormone treatment is a safe and effective therapy that’s often used to treat children and adults with a deficiency in human growth hormone (also known as HGH or somatropin).
The study was prematurely terminated when previously unexpected risks were discovered, specifically the finding that though the all-cause mortality was not affected by the hormone therapy, the benefits of menopausal hormone therapy (reduced risk of hip fracture, colorectal and endometrial cancer and all other causes of death) were offset by ...
[57] [37] [58] As of July 2018, dienogest is in phase III clinical trials in Japan for the treatment of adenomyosis and dysmenorrhea. [8] The combination of estradiol valerate and dienogest is in pre-registration in Europe for the treatment of acne. [59] Dienogest is also being evaluated for the potential treatment of anorexia nervosa. [60]